Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 2, Pages e56760
Publisher
Public Library of Science (PLoS)
Online
2013-02-28
DOI
10.1371/journal.pone.0056760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells
- (2015) Baolin Zhang et al. Oncotarget
- HuR’s post-transcriptional regulation of death receptor 5 in pancreatic cancer cells
- (2012) Danielle M. Pineda et al. CANCER BIOLOGY & THERAPY
- Histone deacetylase (HDAC) inhibitors and regulation of TRAIL-induced apoptosis
- (2012) Simone Fulda EXPERIMENTAL CELL RESEARCH
- Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5
- (2012) Rui Kong et al. PLoS One
- Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma
- (2011) Claus Schäfer et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer
- (2011) Jean-Charles Soria et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
- (2010) T Trarbach et al. BRITISH JOURNAL OF CANCER
- Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)
- (2010) Andres Forero-Torres et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L
- (2010) Hong Zhu et al. CANCER LETTERS
- TRAIL-Induced Apoptosis Is Preferentially Mediated via TRAIL Receptor 1 in Pancreatic Carcinoma Cells and Profoundly Enhanced by XIAP Inhibitors
- (2010) D. Stadel et al. CLINICAL CANCER RESEARCH
- Expression, Cellular Distribution, and Prognostic Relevance of TRAIL Receptors in Hepatocellular Carcinoma
- (2010) L. Kriegl et al. CLINICAL CANCER RESEARCH
- Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma
- (2010) Christian Röder et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
- (2010) Prashant Bavi et al. Molecular Cancer
- HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
- (2010) Susanne Schuler et al. Molecular Cancer
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- New insights into apoptosis signaling by Apo2L/TRAIL
- (2010) F Gonzalvez et al. ONCOGENE
- Apoptosis pathways and their therapeutic exploitation in pancreatic cancer
- (2009) Simone Fulda JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer
- (2009) Tom M. Ganten et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- High TRAIL Death Receptor 4 and Decoy Receptor 2 Expression Correlates With Significant Cell Death in Pancreatic Ductal Adenocarcinoma Patients
- (2009) Ahter Dilsad Sanlioglu et al. PANCREAS
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- OPG Is Regulated by -Catenin and Mediates Resistance to TRAIL-Induced Apoptosis in Colon Cancer
- (2008) E. N. De Toni et al. CLINICAL CANCER RESEARCH
- Prognostic significance of TRAIL-R1 and TRAIL-R3 expression in metastatic colorectal carcinomas
- (2008) Virginie Granci et al. EUROPEAN JOURNAL OF CANCER
- TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development
- (2008) Anne Grosse-Wilde et al. JOURNAL OF CLINICAL INVESTIGATION
- Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Apoptotic pathways in pancreatic ductal adenocarcinoma
- (2008) Rainer Hamacher et al. Molecular Cancer
- TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
- (2008) Y. Zhang et al. MOLECULAR CANCER RESEARCH
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started